135 results on '"van Tuyl, Lilian H. D."'
Search Results
2. Physical Activity in People With Dementia Living in Long-Term Care Facilities and the Connection With Environmental Factors and Behavior
3. Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial
4. Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis
5. RHEUMATOID ARTHRITIS: Remission — keeping the patient experience front and centre
6. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial
7. Patient-reported outcomes in core domain sets for rheumatic diseases
8. The patient perspective on remission in rheumatoid arthritis: ‘Youʼve got limits, but youʼre back to being you again’
9. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development
10. Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias
11. Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al:Â € Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al
12. Patientʼs global assessment of disease activity: What are we measuring?
13. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome
14. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
15. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
16. Defining Remission in Rheumatoid Arthritis: Results of an Initial American College of Rheumatology/European League Against Rheumatism Consensus Conference
17. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
18. Mortality has improved in RA, but we must remain vigilant. Response to: ‘Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA’ by Matthijssen et al
19. Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up
20. PERCEIVED RESILIENCE AND PATIENT SAFETY OF DUTCH NURSING STAFF DURING THE COVID-19 PANDEMIC.
21. Rheumatoid arthritis:Remission - keeping the patient experience front and centre
22. The controversy of using PGA to define remission in RA
23. The patient perspective on absence of disease activity in rheumatoid arthritis:a survey to identify key domains of patient-perceived remission
24. Validating Rheumatoid Arthritis Remission Using the Patients' Perspective:Results from a Special Interest Group at OMERACT 2016
25. Effective Treatment for Rapid Improvement of Both Disease Activity and Self-Reported Physical Activity in Early Rheumatoid Arthritis
26. Remission — keeping the patient experience front and centre
27. Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?
28. Evaluating quality of care in rheumatoid arthritis: the patient perspective
29. The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission
30. One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy
31. The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis
32. Impact of Symptoms on Daily Life in People at Risk of Rheumatoid Arthritis
33. Defining Remission in Rheumatoid Arthritis: Results of an Initial ACR Consensus Conference
34. The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission.
35. The patient perspective on remission in rheumatoid arthritis: ‘You've got limits, but you're back to being you again’
36. Body Mass Index Measurements Have Limited Value for the Assessment of Body Composition in Rheumatoid Arthritis: Comment on the Article by Wolfe and Michaud
37. Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias
38. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome
39. Evidence for predictive validity of remission on long‐term outcome in rheumatoid arthritis: A systematic review
40. Patient Perspective on Remission in Rheumatoid Arthritis.
41. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.
42. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
43. Evidence for predictive validity of remission on longterm outcome in rheumatoid arthritis: A systematic review
44. Patient-reported Remission in Rheumatoid Arthritis.
45. Progress Toward the Development of a New Definition of Remission in Rheumatoid Arthritis.
46. Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?
47. Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review.
48. Potential for pharmacist prescribing in primary care: A Dutch citizen perspective.
49. Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.
50. Physical Activity in People With Dementia Living in Long-Term Care Facilities and the Connection With Environmental Factors and Behavior.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.